30
Betta Pharma
300558.SZ·SZSEHangzhou CNFounded 20033,000 employees
Mid CapbiotechPublicOncology
Platform: EGFR TKI
Market Cap
$3B
All Drugs
3
Clinical Trials
8
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (300558.SZ)
Loading 300558.SZ stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Gelilemzoparlimab | 300-9688 | Preclinical | 2 | BTK | DMD | ||
| 300-9245 | 300-9245 | NDA/BLA | 2 | Nectin-4 | SMAGIST | ||
| 300-2164 | 300-2164 | Phase 3 | 4 | CD38 | MCL |
SEC Filings & Financial Documents
SEC filings are not available for SZSE-listed companies.
Betta Pharma trades on SZSE (CN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (7)